These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37977211)

  • 21. Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents.
    Bajor M; Zych AO; Graczyk-Jarzynka A; Muchowicz A; Firczuk M; Trzeciak L; Gaj P; Domagala A; Siernicka M; Zagozdzon A; Siedlecki P; Kniotek M; O'Leary PC; Golab J; Zagozdzon R
    Br J Cancer; 2018 Oct; 119(7):873-884. PubMed ID: 30287919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxiredoxin 1 knockdown potentiates β-lapachone cytotoxicity through modulation of reactive oxygen species and mitogen-activated protein kinase signals.
    He T; Banach-Latapy A; Vernis L; Dardalhon M; Chanet R; Huang ME
    Carcinogenesis; 2013 Apr; 34(4):760-9. PubMed ID: 23239746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PRDX-1 Supports the Survival and Antitumor Activity of Primary and CAR-Modified NK Cells under Oxidative Stress.
    Klopotowska M; Bajor M; Graczyk-Jarzynka A; Kraft A; Pilch Z; Zhylko A; Firczuk M; Baranowska I; Lazniewski M; Plewczynski D; Goral A; Soroczynska K; Domagala J; Marhelava K; Slusarczyk A; Retecki K; Ramji K; Krawczyk M; Temples MN; Sharma B; Lachota M; Netskar H; Malmberg KJ; Zagozdzon R; Winiarska M
    Cancer Immunol Res; 2022 Feb; 10(2):228-244. PubMed ID: 34853030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxiredoxin 1 promotes pancreatic cancer cell invasion by modulating p38 MAPK activity.
    Taniuchi K; Furihata M; Hanazaki K; Iwasaki S; Tanaka K; Shimizu T; Saito M; Saibara T
    Pancreas; 2015 Mar; 44(2):331-40. PubMed ID: 25426613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor protein D52 (isoform 3) interacts with and promotes peroxidase activity of Peroxiredoxin 1 in prostate cancer cells implicated in cell growth and migration.
    Dasari C; Reddy KRK; Natani S; Murthy TRL; Bhukya S; Ummanni R
    Biochim Biophys Acta Mol Cell Res; 2019 Aug; 1866(8):1298-1309. PubMed ID: 30981892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential parameters between cytosolic 2-Cys peroxiredoxins, PRDX1 and PRDX2.
    Dalla Rizza J; Randall LM; Santos J; Ferrer-Sueta G; Denicola A
    Protein Sci; 2019 Jan; 28(1):191-201. PubMed ID: 30284335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression and function of peroxiredoxin 1 and peroxiredoxin 6 in cancerous MCF-7 and noncancerous MCF-10A breast epithelial cells.
    Goncalves K; Sullivan K; Phelan S
    Cancer Invest; 2012 Jan; 30(1):38-47. PubMed ID: 22236188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prdx1-encoded peroxiredoxin is important for vascular development in zebrafish.
    Huang PC; Chiu CC; Chang HW; Wang YS; Syue HH; Song YC; Weng ZH; Tai MH; Wu CY
    FEBS Lett; 2017 Mar; 591(6):889-902. PubMed ID: 28231391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PRDX1 negatively regulates bleomycin-induced pulmonary fibrosis via inhibiting the epithelial-mesenchymal transition and lung fibroblast proliferation in vitro and in vivo.
    Sun HN; Ren CX; Lee DH; Wang WH; Guo XY; Hao YY; Wang XM; Zhang HN; Xiao WQ; Li N; Cong J; Han YH; Kwon T
    Cell Mol Biol Lett; 2023 Jun; 28(1):48. PubMed ID: 37268886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer.
    Guo QJ; Mills JN; Bandurraga SG; Nogueira LM; Mason NJ; Camp ER; Larue AC; Turner DP; Findlay VJ
    Breast Cancer Res; 2013; 15(4):R70. PubMed ID: 23971998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxiredoxin-1 Tyr194 phosphorylation regulates LOX-dependent extracellular matrix remodelling in breast cancer.
    Attaran S; Skoko JJ; Hopkins BL; Wright MK; Wood LE; Asan A; Woo HA; Feinberg A; Neumann CA
    Br J Cancer; 2021 Oct; 125(8):1146-1157. PubMed ID: 34389806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A metabolic map of the DNA damage response identifies PRDX1 in the control of nuclear ROS scavenging and aspartate availability.
    Moretton A; Kourtis S; Gañez Zapater A; Calabrò C; Espinar Calvo ML; Fontaine F; Darai E; Abad Cortel E; Block S; Pascual-Reguant L; Pardo-Lorente N; Ghose R; Vander Heiden MG; Janic A; Müller AC; Loizou JI; Sdelci S
    Mol Syst Biol; 2023 Jul; 19(7):e11267. PubMed ID: 37259925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PRDX1 enhances cerebral ischemia-reperfusion injury through activation of TLR4-regulated inflammation and apoptosis.
    Liu Q; Zhang Y
    Biochem Biophys Res Commun; 2019 Nov; 519(3):453-461. PubMed ID: 31526567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiological Significance of Plant Peroxiredoxins and the Structure-Related and Multifunctional Biochemistry of Peroxiredoxin 1.
    Lee ES; Kang CH; Park JH; Lee SY
    Antioxid Redox Signal; 2018 Mar; 28(7):625-639. PubMed ID: 29113450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cysteine Oxidation Targets Peroxiredoxins 1 and 2 for Exosomal Release through a Novel Mechanism of Redox-Dependent Secretion.
    Mullen L; Hanschmann EM; Lillig CH; Herzenberg LA; Ghezzi P
    Mol Med; 2015 Feb; 21(1):98-108. PubMed ID: 25715249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunohistochemical detection of peroxiredoxin 1 and 2 in canine spontaneous vascular endothelial tumors.
    Otsuka N; Ishimaru K; Murakami M; Goto M; Hirata A; Sakai H
    J Vet Med Sci; 2022 Jul; 84(7):914-923. PubMed ID: 35584951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomics in HepG2 hepatocarcinoma cells with stably silenced expression of PRDX1.
    Aguilar-Melero P; Prieto-Álamo MJ; Jurado J; Holmgren A; Pueyo C
    J Proteomics; 2013 Feb; 79():161-71. PubMed ID: 23277276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus.
    Jiang Y; Cao W; Wu K; Qin X; Wang X; Li Y; Yu B; Zhang Z; Wang X; Yan M; Xu Q; Zhang J; Chen W
    J Exp Clin Cancer Res; 2019 Aug; 38(1):365. PubMed ID: 31429766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity.
    Cao J; Schulte J; Knight A; Leslie NR; Zagozdzon A; Bronson R; Manevich Y; Beeson C; Neumann CA
    EMBO J; 2009 May; 28(10):1505-17. PubMed ID: 19369943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered Regulation of the Glucose Transporter GLUT3 in PRDX1 Null Cells Caused Hypersensitivity to Arsenite.
    Ali R; Alhaj Sulaiman A; Memon B; Pradhan S; Algethami M; Aouida M; McKay G; Madhusudan S; Abdelalim EM; Ramotar D
    Cells; 2023 Nov; 12(23):. PubMed ID: 38067110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.